Most Recent
Vittoria wins challenge to another Mondelez coffee machine patent
Australian coffee maker Vittoria Food & Beverage has won another challenge to a patent for a coffee pod system filed by a unit of Mondelez International.
Alphapharm slams Sanofi amendment delay in injunction battle
Generic drug maker Alphapharm says rival Sanofi-Aventis waited to amend its injector pen patent until the heated IP battle between the two firms had commenced, despite knowing about the amendments for three years.
‘Disappointed’ judge decries delays in Sydney light rail class action
A judge has expressed frustration at the slow pace of the Sydney light rail class action, forcing both parties to commit to a timetable that will push the proceeding more rapidly towards a final hearing.
Fintech founder to pay for judge to fly to UK for testimony of ex-Visa boss
The founder of a fintech company suing Visa for allegedly abusing its market dominance is flying a Federal Court judge to the UK to preside over the examination of a key but reluctant witness in the case, former Visa boss Rupert Keeley.
UGL knew LNG project was behind schedule by April, class action says
UGL knew by April 2014 that there were delays with the Ichthys LNG project, but failed to make required disclosures to shareholders, according to an amended pleading in a shareholder class action against the engineering company.
Judge OKs $2.5M penalty against hearing aid cos. in ACCC case
A judge has approved a $2.5 million penalty against two hearing aid retailers in the consumer regulator's case alleging the companies targeted vulnerable pensioners with misleading newspaper ads.
Surfstitch class action settlement in peril as debate rages over opt-out notice
Judges do not have the power to approve a class action settlement without first issuing an opt-out notice to group members, the court-appointed contradictor in two shareholder class actions against online fashion retailer Surfstitch told the NSW Supreme Court Thursday.
Funder’s cut, legal fees in $64M Banksia settlement rejected on appeal
An appeals court has rejected the funder's commission and legal fees stemming from a $64 million settlement in litigation over the failure of Banksia Securities, but granted approval to the settlement.
Generic Health wins ‘modest’ cut to Bayer’s $25M damages over Yasmin
Generic Health has shaved two percent off the $25 million damages awarded pharmaceutical giant Bayer in a patent infringement case over Bayer's blockbuster oral contraceptive, Yasmin, but the discount is a far cry from the 15 percent it sought on appeal.
Citing ‘irreparable harm’ Rush tries to keep Nationwide amendments under wraps
Actor Geoffrey Rush is seeking to suppress an amended defence by Nationwide News, arguing that if they're made public the amendments could cause him "irreparable harm".